This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Weiping Luo: Innovator in Angiogenesis Inhibition
Introduction
Weiping Luo is a notable inventor based in Pearland, TX (US). He has made significant contributions to the field of hyperproliferative diseases and angiogenesis. His innovative work focuses on the mechanisms that inhibit angiogenesis, which is crucial for developing treatments for various diseases.
Latest Patents
Weiping Luo holds a patent for a groundbreaking invention titled "C-CAM as an angiogenesis inhibitor." This patent demonstrates that a C-CAM1 cytoplasmic domain is necessary and sufficient for inhibiting angiogenesis. The invention outlines methods for inhibiting hyperproliferative cell growth by administering a C-CAM1 cytoplasmic domain or an expression construct encoding it. Additionally, it describes how angiogenesis can be inhibited by administering a C-CAM1 polypeptide or an expression construct encoding this polypeptide. He has 1 patent to his name.
Career Highlights
Weiping Luo is affiliated with the University of Texas System, where he continues to advance research in his field. His work has implications for treating diseases characterized by excessive angiogenesis, such as cancer.
Collaborations
Weiping has collaborated with notable colleagues, including Sue-Hwa Lin and Christopher Logothetis. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Weiping Luo's contributions to the field of angiogenesis inhibition highlight the importance of innovative research in combating hyperproliferative diseases. His work continues to pave the way for new therapeutic approaches.